Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

FGF-2&D/P nanoparticles can help treat hair loss.

Immunological treatment improved both neuropathy and alopecia.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

A blood pressure drug, diltiazem, may also help treat influenza.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

JAK inhibitors may help improve symptoms in adults with APECED.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

Baricitinib shows promise in treating severe hair loss.

Entospletinib effectively prevents eye and skin GVHD in mice.